# Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis

> **NCT01752335** · PHASE4 · UNKNOWN · sponsor: **Hospital Universitario de Canarias** · enrollment: 28 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **OTHER:** Braquial ecography

## Key facts

- **NCT ID:** NCT01752335
- **Lead sponsor:** Hospital Universitario de Canarias
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2017-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01752335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01752335, "Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01752335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*